Loading…
Employees: 4,141
Size Paras Healthcare (PARASHLTH.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $844M, the 649th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹734.55 on 6 Nov 2026.
Growth Revenue grew 24.1% over the last twelve months (peer median +12.3%); the operating margin is 11.0% (peer median 10.3%).
Valuation It trades at 5.6× enterprise value to sales against a peer median of 3.2× (5th most expensive of 21).
Capital Return on invested capital runs 3.7 points below its cost of capital (12.6% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | n/a | ₹16.1B | ₹12.9B | ₹11.3B | ₹9.18B |
| Revenue growth | — | +24% | +15% | +23% | — |
| Gross profit | n/a | ₹7.20B | ₹2.62B | ₹4.50B | ₹3.69B |
| EBITDA | n/a | ₹3.20B | ₹1.41B | ₹1.23B | ₹1.25B |
| Net income | n/a | ₹438M | -₹580M | -₹153M | -₹428M |
| Free cash flow | n/a | -₹531M | -₹791M | -₹1.34B | -₹834M |
| Capital expenditure | n/a | ₹1.69B | ₹1.37B | ₹1.98B | ₹1.13B |
| Total debt | n/a | ₹13.9B | ₹12.3B | ₹9.24B | ₹7.56B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PARASHLTH.NS | Peer median | Rank in peer set |
|---|---|---|---|
| Revenue growth (TTM) | +24.1% | +12.3% | 2nd highest of 21 |
| Operating margin | 11.0% | 10.3% | 8th highest of 20 |
| EV / Sales | 5.6× | 3.2× | 5th most expensive of 21 |
| ROIC minus cost of capital | -3.7 pp | -2.3 pp | 6th lowest of 20 |
| EV / EBITDA | 28.4× | 16.5× | 2nd most expensive of 17 |
| Net debt / EBITDA | 3.4× | 1.0× | 6th most indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | 5.6× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 2.5× | 0.7% | +19.7% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 3.4× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | 5.5× | 20.9% | +11.8% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 6.0× | n/a | n/a |
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | 4.0× | 16.3% | +18.1% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 6.8× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 0.6× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | 0.9× | 6.3% | +6.0% |
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 8.1× | 30.5% | +10.2% |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 1.7× | 13.7% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 1.8× | -2.4% | +6.1% |
| Garofalo Health Care GHC.MI | Italy | $540M | +1% | +4% | 10% | 1.5× | 1.8% | +18.3% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 6.9× | 30.2% | +21.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 1.4× | 9.8% | +11.4% |
| Artemis Medicare Services ARTEMISMED.NS | India | $514M | +16% | +15% | 14% | 4.4× | 45.8% | +21.5% |
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 5.4× | n/a | n/a |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 1.8× | 26.6% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | 3.2× | 13.6% | +20.6% |
| Bayzed Health 2609.HK | Hong Kong | $453M | -49% | -2% | 5% | 2.9× | 17.4% | +9.2% |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 3.2× | 19.6% | +8.6% |